PCI Biotech Holding ASA

DB:4QG Stock Report

Market Cap: €5.2m

PCI Biotech Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 4QG?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,299,4906.16%
Institutions4,076,86110.9%
Private Companies4,810,44312.9%
General Public26,139,59670%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 15 shareholders own 29.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.5%
Erik Must AS
3,910,443€549.9k0%no data
4.3%
MP Pensjon PK
1,605,801€225.8k0%0.03%
3.84%
Nordnet AB (publ), Asset Management Arm
1,434,803€201.8k0%0.03%
2.33%
Christer Englund
871,062€122.5k0%no data
1.72%
Odd Gresslien
641,000€90.1k0%no data
1.63%
DBS Asset Management (United States) PTE Ltd.
607,974€85.5k0%0.02%
1.4%
Lin Zhang
523,000€73.5k0%no data
1.34%
Ravi Investering As
500,000€70.3k0%no data
1.15%
BNP Paribas Securities Corp, Asset Management Arm
428,283€60.2k0%no data
1.07%
Myrlid AS
400,000€56.2k0%no data
0.33%
Hans Bohn
123,662€17.4k0%no data
0.17%
Anders Hogset
64,800€9.1k0%no data
0.15%
Ronny Skuggedal
55,000€7.7k0%no data
0.035%
Lars Viksmoen
12,966€1.8k0%no data
0.021%
Hilde Steineger
8,000€1.1k0%no data